tRNA-derived second messengers confer bacterial immunity
Valentin-Alvarado, L. E.; Yoon, P. H.; Lopez, S. C.; Shulgina, Y.; Langeberg, C.; Armbruster, E.; Ur-Rehman, M. M.; Loi, K.; Taveneau, C.; Esain-Garcia, I.; Koka, M.; Zhang, Z. T.; Kashin, D.; Schwede, F.; Burgio, G.; OConnell, M. R.; Doherty, E. E.; Cate, J. H. D.; Knott, G. J.; Doudna, J. A.
Show abstract
Bacterial small-molecule messengers that function in diverse immune signaling pathways have been thought to derive strictly from biosynthesis using nucleotide and cofactor substrates. Here we report a nuclease-driven immune signaling pathway in which tRNA cleavage generates a specific small molecule that triggers cell death in response to RNA-guided transcript recognition in prokaryotes. We identify a class of type VI-B CRISPR systems in which the RNA-guided nuclease Cas13 and its accessory transmembrane protein, 2TM{beta}, are co-encoded in an operon and are jointly required for bacteriophage defense. Upon target RNA recognition, Cas13 activates 2TM{beta} by producing mono- and dinucleotide messengers bearing 2',3'-cyclic uridine phosphate ends by tRNA cleavage. Activated 2TM{beta} destroys infected cells by forming a multimeric complex that disrupts cell membranes to mediate cell death. These findings demonstrate RNA-programmed tRNA cleavage for second-messenger biogenesis, revealing a new logic for prokaryotic immune signaling.
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.